رجوع
نطاق اليوم
KWD 9.54
KWD 9.81
نطاق 52 أسبوعًا
KWD 3.97
KWD 18.67
حجم التداول
680,110
متوسط 50 يوم / 200 يوم
KWD 13.00
/
KWD 10.48
الإغلاق السابق
KWD 9.75
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -0.9 | 0.3 |
| P/B | 1.6 | 2.9 |
| ROE % | -102.4 | 3.7 |
| Net Margin % | -36.2 | 3.8 |
| Rev Growth 5Y % | -2.9 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 19.500
+103.5%
Low: KWD 15.000
High: KWD 25.000
مكرر الربحية المستقبلي
14.1
ربحية السهم المستقبلية
KWD 0.690
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.6 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.610
KWD 1.585 – KWD 1.652
|
3.1 B | 1 |
| FY2029 |
KWD 1.337
KWD 1.316 – KWD 1.372
|
3 B | 1 |
| FY2028 |
KWD 1.254
KWD 0.503 – KWD 2.053
|
2.8 B | 3 |
النقاط الرئيسية
Revenue declined -2.85% annually over 5 years
Debt/Equity of 0.12 — conservative balance sheet
Generating 88.30M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.85%
Capital efficient — spends only 0.93% of revenue on capex
النمو
Revenue Growth (5Y)
-2.85%
Revenue (1Y)1.00%
Earnings (1Y)N/A
FCF Growth (3Y)-16.98%
الجودة
Return on Equity
-102.41%
ROIC-3.63%
Net Margin-36.21%
Op. Margin-1.12%
الأمان
Debt / Equity
0.12
Current Ratio0.98
Interest Coverage-0.33
التقييم
P/E Ratio
-0.91
P/B Ratio1.59
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.00% | Revenue Growth (3Y) | -2.12% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2.85% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.72B | Net Income (TTM) | -986.20M |
| ROE | -102.41% | ROA | -36.31% |
| Gross Margin | 15.63% | Operating Margin | -1.12% |
| Net Margin | -36.21% | Free Cash Flow (TTM) | 88.30M |
| ROIC | -3.63% | FCF Growth (3Y) | -16.98% |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 0.98 |
| Interest Coverage | -0.33 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -0.91 | P/B Ratio | 1.59 |
| P/S Ratio | 0.33 | PEG Ratio | -0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 895.73M | Enterprise Value | 789.13M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.72B | 2.70B | 2.84B | 2.84B | 3.06B |
| Net Income | -986.20M | -328.50M | -25.20M | 186.20M | 98.00M |
| EPS (Diluted) | -10.81 | -3.67 | -0.04 | 2.11 | 1.11 |
| Gross Profit | 425.80M | 534.20M | 590.60M | 724.40M | 604.40M |
| Operating Income | -30.60M | -161.90M | 32.00M | 187.10M | 114.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.72B | 3.58B | 4.33B | 4.29B | 4.37B |
| Total Liabilities | 2.15B | 2.22B | 2.62B | 945.30M | 1.11B |
| Shareholders' Equity | 563.50M | 1.36B | 1.71B | 3.34B | 3.26B |
| Total Debt | 68.00M | 1.20B | 1.67B | 63.40M | 77.20M |
| Cash & Equivalents | 174.60M | 118.50M | 108.60M | 112.00M | 94.60M |
| Current Assets | 897.20M | 948.20M | 1.25B | 1.25B | 1.12B |
| Current Liabilities | 913.30M | 949.50M | 778.40M | 699.00M | 826.70M |